News Center

News Center

Home page

Blog Center

News Center

Viwit Pharmaceuticals to Showcase at DCAT Week 2026, Invites Global Partners to New York

Dr. Keene Wei, President of Viwit, Invited to Speak at the 2026 In Vivo Cell Therapy Innovation Summit

Innovation Drives Development, Focus Makes a "Little Giant": Viwit Recognized as a National Specialized, Refined, Distinctive, and Innovative "Little Giant" Enterprise in the Seventh Batch!

Viwit Pharmaceuticals Co., Ltd. Embarks on a New Journey: Fully Focused on Innovation, Driving the Future with Insight and Science

Viwit Pharmaceuticals Granted "Radiation Safety License": A Dual Milestone in Compliance and Innovation

Advancing into a New Chapter: Viwit Pharma Officially Launches Frontier Exploration in Targeted Gene and Cell Therapies

In 2022

Viwit Pharmaceutical Co., Ltd. participated in CPHI Worldwide 2022 held in Frankfurt Germany from November 1st to November 3rd.

Viwit Pharmaceutical Co., Ltd. participated in CPHI Worldwide 2022 held in Frankfurt Germany from November 1st to November 3rd.

As the world's largest pharmaceutical industry exhibition, CPHI has been successfully held for 30 years. It displays the entire pharmaceutical supply chain, from API, P-MEC to FDF. It becomes the largest annual gathering of pharmaceutical professionals all over the world. Viwit met old friends and new business partners at CPHI. We displayed a wonderful enterprise image with our products and services, and promoted our international business through CPHI.

09

2022

/

11

< 1 >

VIWIT

Drug and Medical Device Internet Information Service Filing Number: 沪网药信备字〔2025〕00283号 Internet Information Service Filing Number: 沪ICP备12014533号

Technical Support:China Enterprise Cross-border | SEO Tags

【Business License】

Search